StonvexLoading…
StonvexStonvexStonvexCore line items from NRIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $83.98M | $54.55M | $76.99M | $38.63M |
Operating Income | $-285.67M | $-213.03M | $-155.06M | $-183.87M |
Net Income | $-264.46M | $-193.57M | $-143.95M | $-180.36M |
EPS (Diluted) | $-3.05 | $-2.88 | $-2.65 | $-3.71 |
Total Assets | $688.13M | $669.34M | $355.60M | $416.76M |
Total Liabilities | $149.39M | $142.35M | $155.10M | $113.06M |
Cash & Equivalents | $246.96M | $110.00M | $54.63M | $64.47M |
Free Cash Flow OCF − CapEx | $-263.47M | $-181.86M | $-89.77M | $-172.05M |
Shares Outstanding | 101.81M | 75.87M | 48.72M | 47.17M |